An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
A Look at the Horizon of Cancer Vaccines
Lillian Siu, MD, FRCPC
A Unique Look at the Current and Future Directions of Cancer Vaccines
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.
